MedPath
Found 1 clinical trials|View Analysis
Sort by:

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Phase 1
Completed
Conditions
Pertussis
Interventions
Biological: aP booster
Biological: TdaP booster
Biological: Licensed TdaP booster (Boostrix®)
First Posted Date
2015-03-09
Last Posted Date
2016-03-24
Lead Sponsor
Novartis
Target Recruit Count
315
Registration Number
NCT02382913
Locations
🇧🇪

Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital, Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath